Articles

P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

BJH - volume 11, issue Abstract Book BHS, february 2020

F. Andreozzi , I. Dufour , A. Sogorb , S. Chabert , G. Verstraete , J. Raedemaeker , L. Bamps , S. Bailly MD, F. Jamar , F. Lecouvet , A. Camboni MD, PhD, J-P. Defour PhD, dr. A-C. Pouleur , J. Morelle MD, PhD, M-C. Vekemans MD, PhD

Read more

P.27 IgM related AL amyloidosis: about 2 cases

BJH - volume 11, issue Abstract Book BHS, february 2020

J. Raedemaeker , F. Andreozzi , I. Dufour , L. Bamps , G. Verstraete , S. Chabert , S. Bailly MD, D. Maisin , J-P. Defour PhD, A. Camboni MD, PhD, dr. A-C. Pouleur , B. Gerber , F. Lecouvet , M-C. Vekemans MD, PhD

Read more

Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the Commission Personalised Medicine

BJH - volume 10, issue 6, october 2019

E. Van Valckenborgh PhD, M. Bakkus PhD, E. Boone PhD, A. Camboni MD, PhD, J-P. Defour PhD, B. Denys MD, H. Devos MD, L. Dewispelaere MD, G. Froyen PhD, A. Hébrant PhD, P. Heimann MD, PhD, P. Hermans MD, PhD, E. Heylen PhD, K. Jacobs PhD, F. Lambert MD, M. Le Mercier Apr, PhD, E. Lierman PhD, H. Louagie MD, PhD, B. Maes MD, PhD, M-B. Maes PhD, G. Martens MD, PhD, L. Michaux MD, PhD, F. Nollet PhD, MSc, H.A. Poirel MD, PhD, G. Raicevic PhD, P. Saussoy MD, PhD, T. Tousseyn MD, PhD, M. Van Den Bulcke PhD, P. Vandenberghe MD, PhD, K. Vandepoele PhD, P. Vannuffel PhD, T. Venken PhD, K. Vermeulen PhD

SUMMARY

Molecular diagnostics have an increasing impact on diagnosis, risk stratification and targeted treatment in haemato-oncology. In the framework of a pilot study for the implementation of next-generation sequencing in the Belgian healthcare system, the Commission of Personalised Medicine was founded to give professional and evidence-based advice on the molecular analysis in haemato-oncology. This paper describes its recommendations for NGS analysis in myeloid malignancies. In addition, the minimally required set of genes that must be analysed is defined and algorithms for molecular workflow in myeloid malignancies are proposed.

(BELG J HEMATOL 2019;10(6):241–9)

Read more

P16 Preleukemic phase of chronic myeloid leukemia presenting with an isolated peripheral basocytosis

BJH - 2018, issue Abstract Book BHS, february 2018

F. Dall’Armellina , Y. Berners , L. Maindiaux , A. Capes , J-P. Defour PhD, P. Saussoy MD, PhD, V. Havelange MD, PhD, M-C. Vekemans MD, PhD

Read more

P52 Pancytopenia induced by visceral leishmaniasis in a patient with relapsed multiple myeloma

BJH - 2018, issue Abstract Book BHS, february 2018

S. Amat , M-C. Vekemans MD, PhD, J-P. Defour PhD, J.C. Yombi , I. Stoian , S. Bailly MD

Read more

P60 Monoclonal gammopathy of clinical significance: an IgG-lambda monoclonal gammopathy associated with renal failure, lung disease and cutis laxa

BJH - 2018, issue Abstract Book BHS, february 2018

L. Maindiaux , F. Dall’Armellina , Y. Berners , A. Capes , V. Gillion , J. Lelotte , L. Marot , J-P. Defour PhD, M-C. Vekemans MD, PhD

Read more

P61 Drug induced neutropenia with myelodysplasia with blast excess

BJH - 2018, issue Abstract Book BHS, february 2018

A. Capes , F. Dall’Armellina , Y. Berners , L. Maindiaux , T. Connerotte MD, A. Camboni MD, PhD, P. Saussoy MD, PhD, J-P. Defour PhD, X. Poiré MD, PhD, N. Straetmans MD, PhD, M-C. Vekemans MD, PhD

Read more
X